Literature DB >> 8058282

Late re-opening of macular holes after initially successful treatment with vitreous surgery.

J S Duker1, R Wendel, A C Patel, C A Puliafito.   

Abstract

BACKGROUND: In more than 50% of eyes with idiopathic, full-thickness macular holes, vitrectomy results in clinical closure of the hole and improvement in visual acuity. Other than cataract formation, late complications of the procedure have not been reported.
METHODS: Over a 4-year period, 167 eyes underwent successful vitreous surgery for idiopathic macular holes documented by clinical closure of the hole and an improvement in visual acuity of at least two Snellen lines. The authors retrospectively studied eight of these eyes. All initially had successful surgery; however, they subsequently had spontaneous late re-opening of the macular hole with acute diminution in vision.
RESULTS: Late re-opening developed in these eyes between 2 and 22 months after initial surgery. The mean time for re-opening was 12.5 months. Three of eight eyes underwent a second vitrectomy, which was successful in improving visual acuity in two eyes. Another patient manifested the growth of an epiretinal membrane that apparently sealed the re-opened macular hole and improved vision.
CONCLUSION: Late re-opening can complicate initially successful macular hole surgery and may occur in at least 4.8% (8 of 167) of initially successful operations. Re-opening has been documented as late as 22 months after initial surgery. Repeat vitrectomy with gas injection may result in reclosure of the hole and improvement in vision.

Entities:  

Mesh:

Year:  1994        PMID: 8058282     DOI: 10.1016/s0161-6420(13)31174-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  12 in total

1.  Late reopening of successfully treated macular holes.

Authors:  M Paques; P Massin; P Y Santiago; A C Spielmann; J F Le Gargasson; A Gaudric
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

Review 2.  [Macular hole. Survey and relevant surgical concepts].

Authors:  S Dithmar
Journal:  Ophthalmologe       Date:  2005-02       Impact factor: 1.059

Review 3.  Fourth time lucky: a case of multiple recurrence of a macular hole.

Authors:  H M Hussin; R H Y Asaria; N E Knox Cartwright; R H B Grey
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

4.  Peripheral visual field loss after vitreous surgery for macular holes.

Authors:  S Bopp; K Lucke; U Hille
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

5.  [Rate of reopening of macular holes following cataract operation].

Authors:  A Hager; S Ehrich; W Wiegand
Journal:  Ophthalmologe       Date:  2007-05       Impact factor: 1.059

6.  Phacovitrectomy without prone posture for full thickness macular holes.

Authors:  P R Simcock; S Scalia
Journal:  Br J Ophthalmol       Date:  2001-11       Impact factor: 4.638

Review 7.  A review of current management of vitreomacular traction and macular hole.

Authors:  Alfredo García-Layana; José García-Arumí; José M Ruiz-Moreno; Lluís Arias-Barquet; Francisco Cabrera-López; Marta S Figueroa
Journal:  J Ophthalmol       Date:  2015-03-03       Impact factor: 1.909

8.  Traumatic reopening of macular hole following successful surgical repair.

Authors:  Margaret Wong; Robert L Halpern; James H Frank
Journal:  Int Med Case Rep J       Date:  2017-03-03

9.  Comparison between Cryopreserved and Dehydrated Human Amniotic Membrane Graft in Treating Challenging Cases with Macular Hole and Macular Hole Retinal Detachment.

Authors:  Yu-Hsuan Huang; Der-Chong Tsai; Lei-Chi Wang; Shih-Jen Chen
Journal:  J Ophthalmol       Date:  2020-07-07       Impact factor: 1.909

10.  An Internal Limiting Membrane Plug and Gas Endotamponade for Recurrent or Persistent Macular Hole.

Authors:  Fabrizio Giansanti; Ruggero Tartaro; Tomaso Caporossi; Daniela Bacherini; Alfonso Savastano; Francesco Barca; Stanislao Rizzo
Journal:  J Ophthalmol       Date:  2019-03-07       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.